Sunshine Biopharma
SBFM
8 hedge funds and large institutions have $127K invested in Sunshine Biopharma in 2026 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 3 closing their positions.
0.01% more ownership
Funds ownership: 0.23% → 0.25% (+0.01%)
10% less capital invested
Capital invested by funds: $142K → $127K (-$14.6K)
11% less funds holding
Funds holding: 9 → 8 (-1)
33% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 3
67% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TSS
Two Sigma Securities
New York
|
+$27.7K |
| 2 |
Commonwealth Equity Services
Waltham,
Massachusetts
|
+$15.8K |
| 3 |
XT
XTX Topco
George Town,
Cayman Islands
|
+$6.25K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
-$29K |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$9.05K |
| 3 |
SS
SBI Securities
Tokyo,
Japan
|
-$3.56K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$908 |
| 5 |
Osaic Holdings
Scottsdale,
Arizona
|
-$177 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Citadel Advisors
Miami,
Florida
| $48.1K | -$9.05K | -768 | -14% |
|
|
TSS
2
Two Sigma Securities
New York
| $24.4K | +$27.7K | +2,348 | New |
|
|
XT
3
XTX Topco
George Town,
Cayman Islands
| $22.3K | +$6.25K | +530 | +33% |
|
4
Morgan Stanley
New York
| $15.2K | – | – | – |
|
|
5
Commonwealth Equity Services
Waltham,
Massachusetts
| $14K | +$15.8K | +1,344 | New |
|
|
SS
6
SBI Securities
Tokyo,
Japan
| $1.91K | -$3.56K | -302 | -62% |
|
|
7
UBS Group
Zurich,
Switzerland
| $1.15K | -$908 | -77 | -41% |
|
8
National Bank of Canada
Montreal,
Quebec, Canada
| $9 | – | – | – |
|
|
9
Osaic Holdings
Scottsdale,
Arizona
| $2 | -$177 | -15 | Closed |
|
|
CA
10
CoreCap Advisors
Southfield,
Michigan
| $1 | – | – | – |
|
|
FFA
11
Farther Finance Advisors
San Francisco,
California
| $1 | – | – | – |
|
|
TWC
12
TD Waterhouse Canada
Toronto,
Ontario, Canada
| $1 | – | – | – |
|
|
VF
13
Virtu Financial
New York
| – | -$29K | -2,339 | Closed |
|
14
Bank of America
Charlotte,
North Carolina
| – | -$6 | -1 | Closed |
|
|
SFG
15
Strive Financial Group
Carmel,
Indiana
| – | -$1 | – | – |
|
SBFM Hedge Fund Activity: Q1 2026 in Review
8 of the 8,132 institutional investors tracked by Wall St. Rank reported a position in Sunshine Biopharma (SBFM) for Q1 2026, worth a combined $127K — down 10% from $142K a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of SBFM and 2 opened new positions — a net loss of 1 holder — while 3 trimmed existing stakes and 1 added.
The largest buyer was Two Sigma Securities, opening a new position worth an estimated $27.7K. The largest seller was Virtu Financial, exiting entirely with an estimated $29K sold.
- 8 institutional investors held Sunshine Biopharma (SBFM) as of Q1 2026, down from 9 in Q4 2025.
- Funds reported $127K of Sunshine Biopharma stock for Q1 2026, down 10% quarter-over-quarter.
- 2 funds opened new Sunshine Biopharma positions in Q1 2026 and 3 closed out, a net change of -1 holder.
- The largest Sunshine Biopharma buyer in Q1 2026 was Two Sigma Securities, an estimated $27.7K added.
- The largest Sunshine Biopharma seller in Q1 2026 was Virtu Financial, an estimated $29K sold.
Based on aggregated 13F filings for Q1 2026.